CI

At a glance

ClinicalIndex Comparison Record
Phase 2Recruiting· 128 target
Drug / intervention
Placebo oral liquid and mouthwash +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07339774
NCT07339774Phase 2RecruitingOn TrackUpdated 3mo ago

Chinese Herbal Oral Solution and Mouthwash Shorten the Duration of Severe Radiotherapy-induced Oral Mucositis in Patients With Head and Neck Malignancies.

West China Hospital·interventional·Posted Jan 14, 2026·Updated Mar 25, 2026

In Brief

A Phase 2 clinical trial evaluating Placebo oral liquid and mouthwash, Zishui Daohuo oral liquid combined with Kujiu mouthwash, and 1 other intervention for Radiotherapy-induced Oral Mucositis. Currently recruiting, targeting 128 participants across 1 site.

Detailed Summary

Evaluate the effectiveness and safety of traditional Chinese medicine compound in improving radiotherapy-induced oral mucositis in patients with head and neck malignant tumors.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

Phase 2Recruiting
20262027
First PostedJan 14, 2026
Enrollment StartMar 30, 2026
Primary CompletionOct 31, 2026
Study CompletionDec 30, 2026
TodayJul 1, 2026
Enrollment to primary: 7 monthsPosted 6 months agoPrimary completion in 4 months

Interventions

Placebo oral liquid and mouthwashdrug

Placebo oral liquid and mouthwash with the same color, aroma, and taste as the experimental group, and without any related drug ingredients

Zishui Daohuo oral liquid combined with Kujiu mouthwashdrug

Oral administration of Zishui Daohuo oral liquid combined with gargling using Kujiu mouthwash.

Radiotherapyradiation

One of the inclusion criteria for the study was that patients with squamous carcinoma of the head and neck (including nasopharyngeal carcinoma) needed to receive either radiotherapy alone or simultaneous radiotherapy and chemotherapy.